FDA clos­es the door on Intar­ci­a's eight-year bid for di­a­betes drug-de­vice com­bo

The FDA on Thurs­day is­sued an or­der deny­ing Intar­cia’s ap­peal over its re­ject­ed type 2 di­a­betes com­bo prod­uct, end­ing near­ly eight years of back-and-forth on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER